Bio-Rad Laboratories (BIO) Research & Development (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Research & Development of $62.9 million for Q1 2026, down 14.42% year-over-year from $73.5 million in Q1 2025, and down 10.53% quarter-over-quarter from $70.3 million in Q4 2025.
Bio-Rad Laboratories (BIO) Research & Development (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Research & Development for 18 consecutive years, with $62.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 14.42% year-over-year to $62.9 million; the TTM figure through Mar 2026 stood at $265.0 million (down 12.54% YoY), while the FY2025 annual figure was $275.6 million, down 6.86% from the prior year.
- Research & Development fell to $62.9 million in Q1 2026 per BIO's latest filing, from $70.3 million in the prior quarter.
- Across five years, Research & Development topped out at $91.0 million in Q3 2024 and bottomed at $43.5 million in Q3 2023.
- Historically, Research & Development has averaged $67.0 million across 5 years, with a median of $66.2 million in 2022.
- Annual changes were most pronounced in 2023 — Research & Development tumbled 34.84% — and 2024, when it soared 109.03%.
- Bio-Rad Laboratories' Research & Development stood at $66.2 million in 2022, then decreased by 3.53% to $63.9 million in 2023, then advanced by 24.62% to $79.6 million in 2024, then fell by 11.68% to $70.3 million in 2025, then slipped by 10.53% to $62.9 million in 2026.
- Business Quant data shows BIO's Research & Development at $62.9 million in Q1 2026, $70.3 million in Q4 2025, and $71.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Bio-Rad Laboratories | 9.97 Bn | 8.35 Bn | 345.80 Mn | 61.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.20 Mn |
| Mar 31, 2026 | 62.90 Mn |
| Dec 31, 2025 | 70.30 Mn |
| Sep 30, 2025 | 71.30 Mn |
| Jun 30, 2025 | 60.50 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | 79.60 Mn |
| Sep 30, 2024 | 91.00 Mn |
| Jun 30, 2024 | 58.90 Mn |
| Mar 31, 2024 | 66.40 Mn |
| Dec 31, 2023 | 63.87 Mn |
| Sep 30, 2023 | 43.54 Mn |
| Jun 30, 2023 | 65.04 Mn |
| Mar 31, 2023 | 74.95 Mn |
| Dec 31, 2022 | 66.21 Mn |
| Sep 30, 2022 | 66.81 Mn |
| Jun 30, 2022 | 64.35 Mn |
| Mar 31, 2022 | 59.54 Mn |
| Dec 31, 2021 | 58.85 Mn |
| Sep 30, 2021 | 64.48 Mn |